|
CCDC50 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.0315970300212E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.57660000055238E-07 |
| Normal-vs-Stage2 |
2.523600E-03 |
| Normal-vs-Stage3 |
6.544700E-03 |
| Normal-vs-Stage4 |
6.656900E-03 |
| Stage1-vs-Stage2 |
6.526400E-01 |
| Stage1-vs-Stage3 |
8.471800E-01 |
| Stage1-vs-Stage4 |
3.166800E-01 |
| Stage2-vs-Stage3 |
8.201000E-01 |
| Stage2-vs-Stage4 |
3.260400E-01 |
| Stage3-vs-Stage4 |
3.862400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.02180494568438E-11 |
| Normal-vs-AfricanAmerican |
3.235300E-04 |
| Normal-vs-Asian |
2.865800E-01 |
| Caucasian-vs-AfricanAmerican |
5.175700E-02 |
| Caucasian-vs-Asian |
4.941800E-02 |
| AfricanAmerican-vs-Asian |
6.613900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.85929971208543E-10 |
| Normal-vs-Female |
1.56010000029738E-07 |
| Male-vs-Female |
2.528000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.762600E-03 |
| Normal-vs-Extreme_Weight |
2.12499999999727E-05 |
| Normal-vs-Obese |
6.79260000024939E-07 |
| Normal-vs-Extreme_Obese |
1.067960E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.124000E-01 |
| Normal_Weight-vs-Obese |
2.243000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.691000E-01 |
| Extreme_Weight-vs-Obese |
5.753800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.571600E-01 |
| Obese-vs-Extreme_Obese |
9.226800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.370900E-04 |
| Normal-vs-Age(41-60Yrs) |
9.43145561649317E-12 |
| Normal-vs-Age(61-80Yrs) |
2.06110000000592E-06 |
| Normal-vs-Age(81-100Yrs) |
1.018790E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.312300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.328600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.952600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.381700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.279610E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.399600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.76603176527124E-12 |
| Normal-VS-Type2 PRCC |
1.745650E-02 |
| Normal-VS-KIRP CIMP |
3.92660000000378E-05 |
| Normal-VS-Unclassified PRCC |
1.415390E-03 |
| Type1 PRCC-VS-Type2 PRCC |
5.57279999999771E-05 |
| Type1 PRCC-VS-KIRP CIMP |
4.228000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.127600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.631610E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.526000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.976000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.062290E-02 |
| Normal-vs-N1 |
5.957900E-04 |
| Normal-vs-N2 |
3.011800E-01 |
| N0-vs-N1 |
1.021360E-01 |
| N0-vs-N2 |
7.538400E-01 |
| N1-vs-N2 |
2.809600E-01 |
|
|
